BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11073749)

  • 1. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.
    Norrby-Teglund A; Ihendyane N; Kansal R; Basma H; Kotb M; Andersson J; Hammarström L
    Clin Infect Dis; 2000 Nov; 31(5):1175-82. PubMed ID: 11073749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
    J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy.
    Norrby-Teglund A; Basma H; Andersson J; McGeer A; Low DE; Kotb M
    Clin Infect Dis; 1998 Mar; 26(3):631-8. PubMed ID: 9524835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
    Schrage B; Duan G; Yang LP; Fraser JD; Proft T
    Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
    Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
    Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
    Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of immunoglobulins (IgG, IgA, IgM) in Antarctic summer expeditioners and their relationship with seasickness.
    Mishra KP; Yadav AP; Shweta ; Chanda S; Majumdar D; Ganju L
    Cell Immunol; 2011; 271(1):29-35. PubMed ID: 21714963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent immunoglobulin significantly attenuated the formation of IL-1β in Escherichia coli-induced sepsis in pigs.
    Barratt-Due A; Sokolov A; Gustavsen A; Hellerud BC; Egge K; Pischke SE; Lindstad JK; Pharo A; Castellheim A; Thorgersen EB; Mollnes TE
    Immunobiology; 2013 May; 218(5):683-9. PubMed ID: 22947599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Andersson J; Andersson U; Kotb M
    Infect Immun; 1996 Dec; 64(12):5395-8. PubMed ID: 8945593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation.
    Bar-Dayan Y; Bonnin E; Bloch M; Schweitzer R; Ravid M; Kazatchkine MD; Kaveri SV
    Scand J Immunol; 2000 Apr; 51(4):408-14. PubMed ID: 10736114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
    Tang RG; Yuan XH; Tang TT; Tang XQ; Hang YQ; Qin HJ; Chen HM; Fang WZ; Long XK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():35-8. PubMed ID: 17767855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of antibodies against A60 mycobacterial antigen in tuberculosis diagnosis].
    Zielonka TM; Demkow U; Filewska M; Białas-Chromiec B; Boros P; Załeska J; Radzikowska E; Radziukiewicz-Byszewska D
    Pol Merkur Lekarski; 2002 Jun; 12(72):486-90. PubMed ID: 12362667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contamination of IgG preparation for intravenous use with IgA. I. Development of ELISA tests for determination of low concentrations of IgAc, IgA1, IgA2, IgG and IgM].
    Dovezenski N; Velicković Z; Tosić Lj; Nikolić G; Popović O; Romić M; Djokić M; Mijusković Z
    Srp Arh Celok Lek; 1994; 122 Suppl 1():49-50. PubMed ID: 18173186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of immunoglobulin M-enriched intravenous immunoglobulins against bacterial infections and on the neutralization of bacterial toxins].
    Dichtelmüller H; Stephan W
    Arzneimittelforschung; 1987 Nov; 37(11):1273-6. PubMed ID: 3440036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations.
    Gleicher N; Harlow L
    Mt Sinai J Med; 1990 Sep; 57(4):242-8. PubMed ID: 2123297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.